Vietnam’s Pharmaceutical Sector: A Rapidly Expanding Market
Vietnam’s pharmaceutical industry is experiencing significant growth, ranking as the second-fastest growing in Asia, trailing only India. This expansion is fueled by increasing healthcare spending and a growing population. Average pharmaceutical expenditure is projected to reach $78.3 USD per person in 2025.
The Rise of Imports and Domestic Production
In 2025, Vietnam’s pharmaceutical market is estimated at $8 billion, with $3.5 billion attributed to imports. These imports encompass branded and patented drugs from Europe, biotechnology products and specialized medications from the United States, and a variety of pharmaceuticals from countries like South Korea and India. The remaining portion of the market is supplied by domestic production.
Despite the reliance on imports, Vietnamese pharmaceutical companies are actively increasing their export capabilities. In 2025, 67 Vietnamese firms exported pharmaceutical products and raw materials valued at $312 million to Asia, Europe, and Japan. This positions Vietnam as the fourth-largest exporter in Southeast Asia.
Foreign Investment and Market Dynamics
Foreign investment is playing a crucial role in the growth of Vietnam’s pharmaceutical sector. Recent activity includes strategic stake acquisitions by foreign investors, such as Mirae Asset becoming the second-largest shareholder in a major Vietnamese pharmaceutical company. This influx of capital is expected to further stimulate innovation and expansion within the industry.
Quality Control and Regulatory Oversight
The Vietnamese government is focused on maintaining the quality and safety of pharmaceutical products. In 2025, testing of 40,000 drug samples revealed a low rate of non-compliance, with only 0.6% failing to meet standards. Counterfeit drugs accounted for a very small percentage (0.024%), and 82 batches with quality violations were recalled.
To ensure quality, 46 foreign pharmaceutical manufacturers are now required to inspect all imported batches.
Cosmetics Market Growth
Alongside pharmaceuticals, Vietnam’s cosmetics market is also expanding rapidly. Imports of cosmetics reached $1.27 billion in the first ten months of 2025, with the largest contributions coming from ASEAN countries ($560 million), South Korea ($200 million), China ($170 million), Europe ($110 million), and Japan ($50 million).
Challenges and Opportunities
While the Vietnamese pharmaceutical market presents significant opportunities, challenges remain. These include navigating complex regulatory frameworks, ensuring consistent product quality, and competing with established international players. However, the government’s commitment to promoting the industry, coupled with increasing foreign investment, suggests a positive outlook for future growth.
Frequently Asked Questions
Q: What is the current growth rate of Vietnam’s pharmaceutical industry?
A: It is the second-fastest growing in Asia, after India.
Q: How much of Vietnam’s pharmaceutical market is supplied by imports?
A: Approximately 43.75% ($3.5 billion out of $8 billion) is imported.
Q: What is the Vietnamese government doing to ensure drug quality?
A: They are conducting rigorous testing of drug samples and requiring inspections of imported batches.
Q: Which countries are the main sources of cosmetic imports to Vietnam?
A: ASEAN countries, South Korea, China, Europe, and Japan.
Did you know? Vietnam’s pharmaceutical exports are increasingly driven by companies with foreign direct investment.
Pro Tip: Understanding the regulatory landscape is crucial for companies looking to enter or expand within the Vietnamese pharmaceutical market.
Stay informed about the latest developments in the Vietnamese pharmaceutical industry. Explore more articles on our website or subscribe to our newsletter for regular updates.
Related reading